GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Warrant Pharmaceutical Co Ltd (SHSE:688799) » Definitions » Cash-to-Debt

Hunan Warrant Pharmaceutical Co (SHSE:688799) Cash-to-Debt : 9.82 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hunan Warrant Pharmaceutical Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Hunan Warrant Pharmaceutical Co's cash to debt ratio for the quarter that ended in Mar. 2024 was 9.82.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Hunan Warrant Pharmaceutical Co could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Hunan Warrant Pharmaceutical Co's Cash-to-Debt or its related term are showing as below:

SHSE:688799' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.34   Med: No Debt   Max: No Debt
Current: 9.82

During the past 10 years, Hunan Warrant Pharmaceutical Co's highest Cash to Debt Ratio was No Debt. The lowest was 0.34. And the median was No Debt.

SHSE:688799's Cash-to-Debt is ranked better than
76.21% of 1051 companies
in the Drug Manufacturers industry
Industry Median: 0.93 vs SHSE:688799: 9.82

Hunan Warrant Pharmaceutical Co Cash-to-Debt Historical Data

The historical data trend for Hunan Warrant Pharmaceutical Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Hunan Warrant Pharmaceutical Co Cash-to-Debt Chart

Hunan Warrant Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only No Debt No Debt No Debt No Debt 23.05

Hunan Warrant Pharmaceutical Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt No Debt No Debt 23.05 9.82

Competitive Comparison of Hunan Warrant Pharmaceutical Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Warrant Pharmaceutical Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Warrant Pharmaceutical Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Warrant Pharmaceutical Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Hunan Warrant Pharmaceutical Co's Cash-to-Debt falls into.



Hunan Warrant Pharmaceutical Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Hunan Warrant Pharmaceutical Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Hunan Warrant Pharmaceutical Co's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Warrant Pharmaceutical Co  (SHSE:688799) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Hunan Warrant Pharmaceutical Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Hunan Warrant Pharmaceutical Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Warrant Pharmaceutical Co (SHSE:688799) Business Description

Traded in Other Exchanges
N/A
Address
Liuyang Biomedical Park, Hunan Province, Changsha, CHN, 410331
Hunan Warrant Pharmaceutical Co Ltd is a pharmaceutical manufacturer. It is engaged in the research and development, production and sales of chemical raw materials, chemical medicine preparations and Chinese medicine preparations.
Executives
Jin Yan Supervisors

Hunan Warrant Pharmaceutical Co (SHSE:688799) Headlines

No Headlines